Sellas Receives EMA Orphan Drug Designation for Sls009 for Treatment of Peripheral T-Cell Lymphomas
Sellas獲得歐洲藥品管理局孤兒藥物認定,用於治療外周T細胞淋巴瘤的Sls009。
Sellas Receives EMA Orphan Drug Designation for Sls009 for Treatment of Peripheral T-Cell Lymphomas
Sellas獲得歐洲藥品管理局孤兒藥物認定,用於治療外周T細胞淋巴瘤的Sls009。
譯文內容由第三人軟體翻譯。